State Street’s Cellectis CLLS Stock Holding History

State Street’s Portfolio CLLS Stock Details CLLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-262,368	Closed	-$601K	–	4867
2022 Q3	$601K	Buy	262,368 +8,643	+3%	+$26.2K	﹤0.01%	3708
2022 Q2	$718K	Buy	253,725 +134,164	+112%	+$472K	﹤0.01%	3708
2022 Q1	$543K	Buy	119,561 +4,297	+4%	+$23.7K	﹤0.01%	4017
2021 Q4	$936K	Buy	115,264 +95,621	+487%	+$940K	﹤0.01%	3829
2021 Q3	$248K	Buy	19,643 +408	+2%	+$5.65K	﹤0.01%	4280
2021 Q2	$298K	Sell	19,235 -18,568	-49%	-$312K	﹤0.01%	4055
2021 Q1	$764K	Sell	37,803 -1,833	-5%	-$45.3K	﹤0.01%	3678
2020 Q4	$1.07M	Sell	39,636 -21,200	-35%	-$476K	﹤0.01%	3543
2020 Q3	$1.13M	Sell	60,836 -598	-1%	-$10.6K	﹤0.01%	3403
2020 Q2	$1.09M	Buy	+61,434	New	+$935K	﹤0.01%	3398

Other funds holding CLLS

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

State Street's CLLS Position: Q4 2022 in Review

State Street sold out of Cellectis (CLLS) in Q4 2022, closing a stake of 262,368 shares — an estimated $601K sold.

State Street first reported a position in CLLS in Q2 2020 and held it in 10 quarters. The position peaked at $1.13M in Q3 2020. 40 funds tracked by Wall St. Rank hold CLLS as of Q4 2022.

State Street reported no remaining Cellectis position as of Q4 2022 after selling out during the quarter.
State Street sold 262,368 Cellectis shares in Q4 2022, an estimated $601K.
State Street first reported a position in Cellectis in Q2 2020 and held it in 10 quarters.
State Street's Cellectis position peaked at $1.13M in Q3 2020.
40 funds tracked by Wall St. Rank held Cellectis as of Q4 2022.

Based on State Street's 13F filing for Q4 2022, filed 14 Feb 2023.